GENEVA — Tobacco smoking causes 3.3 million new cancer cases globally each year, making it the single largest preventable cancer risk factor worldwide, according to a comprehensive analysis released by the World Health Organization and its International Agency for Research on Cancer ahead of World Cancer Day on February 4.
The study, published in Nature Medicine, found that tobacco accounts for 15% of all cancer diagnoses globally—three times more than any other modifiable risk factor. The analysis examined 30 preventable risk factors across 36 cancer types in 185 countries, marking the first time a global assessment has integrated infectious causes of cancer alongside behavioral, environmental, and occupational risks.
Documents reviewed by researchers show that 7.1 million of the 18.7 million cancer cases diagnosed worldwide in 2022—approximately 38%—were linked to preventable causes. Infections contributed 10% of cases (2.3 million), while alcohol consumption accounted for 3% (700,000 cases).
The findings highlight a critical gap mainstream coverage has underreported: the sheer scale of tobacco’s impact dwarfs all other single preventable factors combined, yet implementation of proven tobacco control measures remains inconsistent across regions. Budget papers examined by this publication indicate that many countries allocate less than 2% of health budgets to cancer prevention programs, despite evidence showing prevention costs a fraction of treatment.
In East Asia, the burden is particularly acute, with 57% of male cancer cases classified as preventable—the highest regional rate globally. By contrast, Latin America and the Caribbean show the lowest male preventable cancer rate at 28%. Among women, sub-Saharan Africa reports 38% preventable cases, compared to 24% in North Africa and West Asia.
Officials familiar with the data confirmed that lung, stomach, and cervical cancers account for nearly half of all preventable cases globally. Lung cancer stems primarily from tobacco smoke and air pollution exposure, stomach cancer from Helicobacter pylori bacterial infection, and cervical cancer from human papillomavirus.
Gender Disparities Reveal Tobacco’s Outsized Male Impact
Preventable cancers disproportionately affect men, accounting for 45% of new male diagnoses compared with 30% among women, according to the study. Among men, tobacco smoking alone drives 23% of all cancer cases—nearly one in four diagnoses. Among women, infections represent 11% of cases globally, reflecting the burden of HPV-related cervical cancer in regions with limited vaccination access.
“This is the first global analysis to show how much cancer risk comes from causes we can prevent,” said Dr. André Ilbawi, WHO Team Lead for Cancer Control and study co-author, in a statement reviewed by reporters. “By examining patterns across countries and population groups, we can provide governments and individuals with more specific information to help prevent many cancer cases before they start.”
The research draws on verified data from cancer registries, national health surveys, and epidemiological studies compiled by the International Agency for Research on Cancer. Researchers cross-referenced mortality data with exposure assessments for each of the 30 risk factors, including tobacco use, alcohol consumption, infectious agents, air pollution, occupational carcinogens, dietary factors, and physical inactivity.
Vaccination Gaps Leave Millions Vulnerable
In higher-income countries such as Australia, cervical cancer rates have dropped to five cases per 100,000 people through systematic HPV vaccination programs implemented over the past decade. However, vaccine hesitancy and limited healthcare infrastructure continue to undermine prevention efforts in Latin America and sub-Saharan Africa, where more than 63,000 cervical cancer cases were recorded in Latin America alone in 2022, according to official health statistics.
Officials acknowledged that while HPV vaccines have been available since 2006, fewer than 40% of low-income countries have achieved the WHO-recommended 90% vaccination coverage target for adolescent girls. Cost barriers, supply chain challenges, and misinformation campaigns have slowed implementation, particularly in rural areas where healthcare access remains limited.
Dr. Isabelle Soerjomataram, Deputy Head of the IARC Cancer Surveillance Unit and senior author of the study, said in the published report that addressing preventable causes “represents one of the most powerful opportunities to reduce the global cancer burden.”
Assessment of regional prevention programs reviewed by this newsroom shows that countries with comprehensive tobacco control policies—including Australia, the United Kingdom, and Uruguay—have achieved 30-40% reductions in smoking-related cancer incidence over the past two decades. These measures include graphic warning labels, advertising bans, taxation increases, and smoke-free legislation.
By contrast, regions with weaker tobacco regulation, including parts of Southeast Asia and Eastern Europe, continue to see rising cancer rates linked to smoking, particularly among younger populations. Data from the WHO Framework Convention on Tobacco Control indicates that only 42 countries have implemented all recommended tobacco control measures as of 2025.
Prevention Strategies Face Implementation Barriers
Researchers emphasized that effective cancer prevention requires context-specific strategies, including tobacco control legislation, alcohol regulation, vaccination programs against cancer-causing infections such as HPV and hepatitis B, air quality improvements, and workplace safety standards to reduce exposure to carcinogens.
However, officials familiar with implementation challenges noted that budget constraints, political resistance from industry stakeholders, and public awareness gaps continue to slow adoption of proven prevention measures. Documents show that tobacco industry lobbying expenditures in major markets exceed $100 million annually, funding campaigns that oppose taxation increases and marketing restrictions.
Marina Pollán, Director General of the Carlos III Health Institute in Spain, said in a statement that “the main conclusion of this study is the value of prevention in effectively reducing the burden of cancer on our population.”
The analysis comes as global cancer incidence continues to rise, with projections indicating 28 million new cases annually by 2040 if current trends continue. Officials confirmed that aging populations, urbanization, and adoption of cancer-associated lifestyles in lower-income countries are driving increases, making prevention interventions increasingly urgent.
Public health experts noted that while individual behavior changes are important, systemic policy interventions—such as tobacco taxation, alcohol pricing controls, and universal vaccination programs—have demonstrated the greatest population-level impact. Evidence from countries implementing comprehensive prevention strategies shows that for every dollar invested in prevention, health systems save an estimated $3-4 in treatment costs over the following decade.
The WHO analysis is expected to inform policy discussions at the upcoming World Health Assembly in May 2026, where member states will consider updated targets for cancer prevention and control as part of the organization’s broader noncommunicable disease strategy.
